Patent · US Active

Conjugates of synthetic TLR agonists and uses therefor

US8790655B2 · kind B2 · utility

14Cited by

51References

12Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Dennis A. Carson · Del Mar, US
Howard B. Cottam · Escondido, US
Wolfgang Wrasidlo · Village of La Jolla, US
Christina C.N. Wu · Escondido, US
Gregory A. Daniels · San Diego, US

Key dates

Filing date	Jan 8, 2013
Grant date	Jul 29, 2014
Priority date	—
Expiry date	Jan 8, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55555
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides TLR agonists and conjugates thereof useful in vaccines and to prevent, inhibit or treat a variety of disorders including pathogen infection and asthma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.